课题基金 / 基金详情

Cardiac electrophysiology evaluation system for improved drug assessment

Cardiac electrophysiology evaluation system for improved drug assessment
用于改进药物评估的心脏电生理学评估系统
批准号:
22K12801
负责人:
李 俊君
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2022
资助国家:
日本
项目状态:
未结题
起止时间:
2022-04-01 至 2025-03-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
我们计划在二维板上复制行波,并优化获得成熟hiPSC衍生心肌细胞的最佳条件,将行波成熟心肌细胞与成体细胞进行比较。一年中取得的成就包括:1.;在平板和纳米纤维片上培养的心脏组织中都产生了行波。利用MEA可以记录心脏组织的电信号。2.通过染色、透射电镜、rnas测序等方法证实行波成熟心肌细胞的成熟度。将其成熟程度与人类成人进行了比较。3. 在日本流通学会第87届年度科学会议上发表论文2篇并作口头报告,获得青年研究员奖。
英文摘要
We planned to reproduce the traveling wave on 2D plate and optimize the best condition for obtain matured hiPSC derived cardiomyocytes, to compare the traveling wave matured cardiomyocytes with adult cells. The achievements in the year include: 1. The traveling wave has been generated in cardiac tissue cultured on both plate and nanofiber sheets. The electrical signal of cardiac tissue could be recorded by using MEA. 2.The maturity of traveling wave matured cardiomyocytes has been confirmed by using staining, TEM, RNAsequencing and other methods. Their maturation level has been compared with those from human adult. 3. We published 2 papers and gave an oral presentation in 87th Annual Scientific Meeting of the Japanese Circulation Society, and obtained the young investigator award.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human iPSC-derived closed-loop cardiac tissue for improved drug assessment
人类 iPSC 来源的闭环心脏组织可改善药物评估
DOI: --
发表时间: 2023
期刊:
影响因子: --
作者: [Ying Hua, Junjun Li, Xiang Qu, Jingbo Zhang, Masako Ishida, Noriko Yoshida, Hayato Miyoshi, Mikio Shiba3, Shuichiro Higo4,5, Nagako Sougawa1, Maki Takeda1, Takuji Kawamura1, Ryohei Matsuura, Toshihiko Toyofuku, Yoshiki Sawa, Li Liu and Shigeru Miyagawa]
通讯作者: Li Liu and Shigeru Miyagawa
海外基金